评估青少年和年轻成人接种COVID-19疫苗后突发心脏死亡的风险——俄勒冈州,2021年6月至2022年12月
为评估接种COVID-19疫苗后青少年和年轻成人突发心脏死亡的可能性,研究者检索了俄勒冈州2021年6月至2022年12月期间16-30岁居民死亡证明,查找心脏或死因不明者,并查阅免疫信息系统记录接种mRNA COVID-19疫苗后≤100天内死亡情况。在1,292例死亡中,30例死因为COVID-19;101例不能排除心脏死因,其中88例有免疫记录,3例在死亡前100天内接种过mRNA疫苗。40例接种过mRNA疫苗者中3例在接种后≤100天内死亡,其中2例死于慢性基础疾病,1例死因不明。无死亡证明将死因归因于疫苗接种。数据不支持mRNA COVID-19疫苗接种与既往健康年轻人突发心脏死亡之间存在关联。推荐所有≥6月龄人群接种COVID-19疫苗以预防COVID-19及其并发症包括死亡。
要点
- 在1,292例16-30岁死亡者中,仅3例在接种mRNA COVID-19疫苗后≤100天内死亡且不能排除心脏死因。
- 无死亡证明将死因归因于COVID-19疫苗接种。
- 数据不支持mRNA COVID-19疫苗接种与既往健康年轻人突发心脏死亡之间存在关联。
核心结论
- 数据不支持mRNA COVID-19疫苗接种与既往健康年轻人突发心脏死亡之间存在关联。
- 推荐所有≥6月龄人群接种COVID-19疫苗以预防COVID-19及其并发症包括死亡。
研究设计与样本
- 研究者检索俄勒冈州2021年6月至2022年12月期间16-30岁居民死亡证明,识别心脏或死因不明者,并查阅免疫信息系统记录死亡前≤100天内mRNA COVID-19疫苗接种情况。
主要发现
- 在1,292例死亡中,COVID-19被列为30例的死因;另101例不能排除心脏死因,其中88例有免疫信息系统记录,3例在死亡前100天内接种过mRNA COVID-19疫苗。
- 在40例接种过mRNA COVID-19疫苗者的死亡中,3例发生在接种后≤100天内;其中2例归因于慢性基础疾病,1例死因不明。
- 无死亡证明将死因归因于疫苗接种。
临床怎么用
- 推荐所有≥6月龄人群接种COVID-19疫苗以预防COVID-19及其并发症包括死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 vaccination has been associated with myocarditis in adolescents and young adults, and concerns have been raised about possible vaccine-related cardiac fatalities in this age group. In April 2021, cases of myocarditis after COVID-19 vaccination, particularly among young male vaccine recipients, were reported to the Vaccine Adverse Event Reporting System. To assess this possibility, investigators searched death certificates for Oregon residents aged 16-30 years who died during June 2021-December 2022 for cardiac or undetermined causes of death. For identified decedents, records in Oregon's immunization information system were reviewed for documentation of mRNA COVID-19 vaccination received ≤100 days before death. Among 1,292 identified deaths, COVID-19 was cited as the cause for 30. For 101 others, a cardiac cause of death could not be excluded; among these decedents, immunization information system records were available for 88, three of whom had received an mRNA COVID-19 vaccination within 100 days of death. Of 40 deaths that occurred among persons who had received an mRNA COVID-19 vaccine dose, three occurred ≤100 days after vaccination. Two of these deaths were attributed to chronic underlying conditions; the cause was undetermined for one. No death certificate attributed death to vaccination. These data do not support an association between receipt of mRNA COVID-19 vaccine and sudden cardiac death among previously healthy young persons. COVID-19 vaccination is recommended for all persons aged ≥6 months to prevent COVID-19 and complications, including death.
引用
- Liko J, Cieslak PR. Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38602888. doi:10.15585/mmwr.mm7314a5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。